Cargando…
Collection of Post-treatment PRO Data in Oncology Clinical Trials
As patient-reported outcome (PRO) measures are being included more frequently in oncology clinical trials, regulatory and health technology assessment agencies have begun to request long-term, post-treatment PRO data to supplement traditional survival/progression endpoints. These data may be collect...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785546/ https://www.ncbi.nlm.nih.gov/pubmed/32643079 http://dx.doi.org/10.1007/s43441-020-00195-3 |